Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Disclaimer
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Leaf, A.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Leaf, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


The electrophysiological basis for the antiarrhythmic actions of polyunsaturated fatty acids

A. Leaf*

Departments of Medicine, Massachusetts General Hospital and the Harvard Medical School, Boston, MA, USA

* Correspondence: Alexander Leaf, MD, Massachusetts General Hospital, East Bldg 149, 13th Street, Charlestown, MA 02129, USA

Abstract

Aims To determine whether n-3 polyunsaturated fatty acids (PUFAs) have cardiac antiarrhythmic effects and, if so, to determine the basis(es) for such an effect.

Methods and results First, tests were made of the ability of administering n-3 PUFAs to a reliable dog model to prevent ischaemia-induced sudden cardiac death. Infusion of an emulsion of fish oil free fatty acids just prior to coronary artery obstruction prevented ventricular fibrilation (VF) () in exercising, unanaesthetized dogs. Similar results were obtained with pure n-3 free docosahexaenoic, eicosapentaenoic or alpha-linolinic acids.

PUFAs prevented induced fibrillation of cultured neonatal rat cardiomyocytes for all cardiotoxins tested. After fibrillation was induced, the arrhythmias were terminated by the PUFAs. The electrophysiological effects of low micromolar concentrations of PUFAs are to increase the depolarizing current required to elicit an action potential by about 50% and prolong the refractory period by about threefold. These effects result because the PUFAs modulate the conductance of ion channels, primarily of Na+ and Ca2+, in cardiomyocytes from neonatal and adult rats and the human myocardial Na+ channel with the alpha-subunit and the alpha+beta-subunits transiently expressed in HEK293t cells using whole cell patch-clamp.

Conclusions These dietary PUFAs are shown to be potent, safe antiarrhythmic agents. More clinical trials, such as the GISSI-Prevenzione, are needed to extend these findings to humans. Potential, very large public health benefits may accrue from this new understanding.

Key Words: Omega-3 • n-3 • omega-6 • n-6 • eicosapentaenoic acid • docosahexaenoic acid • arrhythmias • seizures


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
M. F. Oliver
Sudden unexpected cardiac death
Eur. Heart J., December 1, 2002; 23(23): 1797 - 1798.
[Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.